MCW	O	O
1863946	O	O
PE	O	O
CT	O	O
THORAX	O	O
&	O	O
CT	O	O
PELVIS	O	O
-LRB-	O	O
915A-B	O	O
-RRB-	O	O
:	O	O
COMPARISON	O	O
:	O	O
NONE	O	O
.	O	O
HELICAL	O	O
ACQUISITION	O	O
WAS	O	O
PERFORMED	O	O
THROUGH	O	O
THE	O	O
CHEST	O	O
AFTER	O	O
THE	O	O
IV	O	O
ADMINISTRATION	O	O
OF	O	O
115	O	O
CC	O	O
OF	O	O
VISIPAQUE	O	O
AND	O	O
1.25	O	O
MM	O	O
AXIAL	O	O
IMAGES	O	O
WERE	O	O
CONSTRUCTED	O	O
.	O	O
DELAYED	O	O
NONCONTIGUOUS	O	O
5	O	O
MM	O	O
IMAGES	O	O
WERE	O	O
OBTAINED	O	O
THROUGH	O	O
THE	O	O
THIGHS	O	O
.	O	O
CORONAL	O	O
AND	O	O
SAGITTAL	O	O
RECONSTRUCTIONS	O	O
WERE	O	O
OBTAINED	O	O
.	O	O
SUBOPTIMAL	1_Red_Minutes	O
OPACIFICATION	1_Red_Minutes	O
OF	1_Red_Minutes	O
PULMONARY	1_Red_Minutes	O
ARTERIAL	1_Red_Minutes	O
VASCULATURE	1_Red_Minutes	O
IS	O	O
PRESENT	O	O
.	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	O
PULMONARY	O	O
THROMBOEMBOLUS	O	O
IS	O	O
IDENTIFIED	O	O
.	O	O
DISTAL	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
ARTERIES	3_Yellow_Days	3_Yellow_Days
ARE	3_Yellow_Days	3_Yellow_Days
ENLARGED	3_Yellow_Days	3_Yellow_Days
MOST	3_Yellow_Days	O
CONSISTENT	3_Yellow_Days	O
WITH	3_Yellow_Days	O
VASCULAR	3_Yellow_Days	O
CONGESTION	3_Yellow_Days	O
.	O	O
DIFFUSE	3_Yellow_Days	3_Yellow_Days
GROUND-GLASS	3_Yellow_Days	3_Yellow_Days
OPACITIES	3_Yellow_Days	3_Yellow_Days
ARE	O	O
NOTED	O	O
THROUGHOUT	3_Yellow_Days	O
THE	3_Yellow_Days	O
UPPER	3_Yellow_Days	O
,	3_Yellow_Days	O
MIDDLE	3_Yellow_Days	O
,	3_Yellow_Days	O
AND	3_Yellow_Days	O
LOWER	3_Yellow_Days	O
LOBES	3_Yellow_Days	O
MOST	3_Yellow_Days	O
CONSISTENT	3_Yellow_Days	O
WITH	3_Yellow_Days	O
INTERSTITIAL	3_Yellow_Days	1_Red_Minutes
EDEMA	3_Yellow_Days	1_Red_Minutes
.	O	O
BILATERAL	O	3_Yellow_Days
LOWER	O	3_Yellow_Days
LOBE	O	3_Yellow_Days
ATELECTASIS	O	3_Yellow_Days
IS	O	3_Yellow_Days
PRESENT	O	3_Yellow_Days
WITH	O	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
EFFUSIONS	3_Yellow_Days	3_Yellow_Days
,	O	3_Yellow_Days
RIGHT	O	O
GREATER	O	O
THAN	O	O
LEFT	O	O
.	O	O
GREAT	O	O
VESSELS	O	O
,	O	O
THORACIC	O	O
AORTA	O	O
,	O	O
AND	O	O
MEDIASTINUM	O	O
ARE	O	O
NORMAL	O	O
.	O	O
THE	O	O
HEART	3_Yellow_Days	O
IS	3_Yellow_Days	O
ENLARGED	3_Yellow_Days	O
.	3_Yellow_Days	O
CALCIFIC	3_Yellow_Days	O
ATHEROSCLEROTIC	3_Yellow_Days	O
VASCULAR	3_Yellow_Days	O
DISEASE	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
CORONARY	3_Yellow_Days	O
VESSELS	3_Yellow_Days	O
IS	O	O
PRESENT	O	O
.	O	O
LIMITED	O	O
IMAGES	O	O
OF	O	O
THE	O	O
UPPER	O	O
ABDOMEN	O	O
ARE	O	O
NORMAL	O	O
.	O	O
REASONABLE	O	O
OPACIFICATION	O	O
OF	O	O
THE	O	O
DEEP	O	O
VENOUS	O	O
SYSTEM	O	O
IS	O	O
PRESENT	O	O
FROM	O	O
THE	O	O
ILIAC	O	O
VEINS	O	O
THROUGH	O	O
POPLITEAL	O	O
VEINS	O	O
.	O	O
NO	O	O
THROMBOSIS	O	O
PRESENT	O	O
.	O	O
MULTIPLE	O	O
SURGICAL	O	O
CLIPS	O	O
ARE	O	O
NOTED	O	O
THROUGHOUT	O	O
THE	O	O
LOWER	O	O
ABDOMEN	O	O
AND	O	O
PELVIS	O	O
CONSISTENT	O	O
WITH	O	O
CYSTOPROSTATECTOMY	O	O
CHANGES	O	O
.	O	O
NO	O	O
FOCAL	O	O
OSSEOUS	O	O
DESTRUCTIVE	O	O
LESIONS	O	O
ARE	O	O
PRESENT	O	O
.	O	O
SIGNIFICANT	3_Yellow_Days	O
OSTEOPHYTE	3_Yellow_Days	O
FORMATION	3_Yellow_Days	O
AND	3_Yellow_Days	O
DEGENERATIVE	3_Yellow_Days	O
CHANGES	3_Yellow_Days	O
THROUGHOUT	3_Yellow_Days	O
THE	3_Yellow_Days	O
THORACOLUMBAR	3_Yellow_Days	O
SPINE	3_Yellow_Days	O
ARE	O	O
PRESENT	O	O
.	O	O
OVERLYING	O	O
SOFT	O	O
TISSUES	O	O
ARE	O	O
OTHERWISE	O	O
UNREMARKABLE	O	O
.	O	O
1	O	O
.	O	O
SOMEWHAT	1_Red_Minutes	O
SUBOPTIMAL	1_Red_Minutes	O
EXAMINATION	1_Red_Minutes	O
WITH	1_Red_Minutes	O
NO	1_Red_Minutes	O
EVIDENCE	1_Red_Minutes	O
OF	1_Red_Minutes	O
PULMONARY	1_Red_Minutes	O
THROMBOEMBOLISM	1_Red_Minutes	O
OR	1_Red_Minutes	O
DEEP	1_Red_Minutes	O
VENOUS	1_Red_Minutes	O
THROMBOSIS	1_Red_Minutes	O
.	O	O
2	O	O
.	O	O
CARDIOMEGALY	3_Yellow_Days	3_Yellow_Days
WITH	3_Yellow_Days	3_Yellow_Days
MILD	3_Yellow_Days	3_Yellow_Days
CONGESTIVE	3_Yellow_Days	3_Yellow_Days
FAILURE	3_Yellow_Days	3_Yellow_Days
.	O	O
3	O	O
.	O	O
BILATERAL	O	3_Yellow_Days
LOWER	O	3_Yellow_Days
LOBE	O	3_Yellow_Days
ATELECTASIS	O	3_Yellow_Days
.	O	O
4	O	O
.	O	O
BILATERAL	3_Yellow_Days	3_Yellow_Days
PLEURAL	3_Yellow_Days	3_Yellow_Days
EFFUSIONS	3_Yellow_Days	3_Yellow_Days
.	O	O
5	O	O
.	O	O
POSTOPERATIVE	O	O
CHANGES	O	O
FROM	O	O
CYSTOPROSTATECTOMY	O	O
.	O	O
6	O	O
.	O	O
CALCIFIED	3_Yellow_Days	3_Yellow_Days
ATHEROSCLEROTIC	3_Yellow_Days	3_Yellow_Days
VASCULAR	3_Yellow_Days	3_Yellow_Days
DISEASE	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
CORONARY	3_Yellow_Days	3_Yellow_Days
ARTERIES	3_Yellow_Days	3_Yellow_Days
.	O	O
7	O	O
.	O	O
SEVERE	3_Yellow_Days	O
DEGENERATIVE	3_Yellow_Days	O
CHANGES	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
THORACOLUMBAR	3_Yellow_Days	O
SPINE	3_Yellow_Days	O
.	O	O
+	O	O
EXAMINATION	O	O
REVIEWED	O	O
&	O	O
REPORTED	O	O
FINDINGS	O	O
CONFIRMED	O	O
BY	O	O
:	O	O
-LSB-	O	O
doctor	O	O
-RSB-	O	O
.	O	O
MCW	O	O
1821665	O	O
AMS	O	O
CT	O	O
THORAX	O	O
&	O	O
CT	O	O
PELVIS	O	O
-LRB-	O	O
745B-C	O	O
-RRB-	O	O
:	O	O
TECHNIQUE	O	O
:	O	O
HELICAL	O	O
CT	O	O
OF	O	O
THE	O	O
CHEST	O	O
WAS	O	O
PERFORMED	O	O
FOLLOWING	O	O
ADMINISTRATION	O	O
OF	O	O
120	O	O
CC	O	O
OF	O	O
OMNIPAQUE-350	O	O
.	O	O
1.25	O	O
MM	O	O
AXIAL	O	O
IMAGES	O	O
AND	O	O
2.5	O	O
MM	O	O
CORONAL	O	O
AND	O	O
SAGITTAL	O	O
IMAGES	O	O
WERE	O	O
REVIEWED	O	O
.	O	O
DELAYED	O	O
NONCONTIGUOUS	O	O
IMAGES	O	O
THROUGH	O	O
THE	O	O
UPPER	O	O
PORTION	O	O
OF	O	O
THE	O	O
LOWER	O	O
EXTREMITIES	O	O
WERE	O	O
LATER	O	O
ACQUIRED	O	O
.	O	O
COMPARISON	O	O
STUDY	O	O
CT	O	O
CHEST	O	O
WITH	O	O
CONTRAST	O	O
DATED	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
.	O	O
THE	O	O
OPACIFICATION	O	O
OF	O	O
THE	O	O
PULMONARY	O	O
VESSELS	O	O
IS	O	O
ADEQUATE	O	O
.	O	O
THERE	O	O
IS	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	O
PULMONARY	O	O
EMBOLISM	O	O
.	O	O
THERE	O	O
IS	O	O
UNCHANGED	O	3_Yellow_Days
INCREASED	O	3_Yellow_Days
CALIBER	O	3_Yellow_Days
OF	O	3_Yellow_Days
THE	O	3_Yellow_Days
CENTRAL	O	3_Yellow_Days
PULMONARY	O	3_Yellow_Days
ARTERIES	O	3_Yellow_Days
INDICATING	O	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
HYPERTENSION	3_Yellow_Days	3_Yellow_Days
.	O	O
THERE	O	O
IS	O	O
DIFFUSE	1_Red_Minutes	3_Yellow_Days
MARKED	1_Red_Minutes	3_Yellow_Days
CARDIOMEGALY	1_Red_Minutes	3_Yellow_Days
WITH	1_Red_Minutes	O
HYPERTROPHY	1_Red_Minutes	1_Red_Minutes
OF	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
LEFT	1_Red_Minutes	1_Red_Minutes
VENTRICLE	1_Red_Minutes	1_Red_Minutes
AND	1_Red_Minutes	1_Red_Minutes
MARKED	1_Red_Minutes	1_Red_Minutes
ENLARGEMENT	1_Red_Minutes	1_Red_Minutes
OF	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
ATRIUM	1_Red_Minutes	O
.	O	O
THE	O	O
INTERVENTRICULAR	O	O
SEPTUM	O	O
IS	O	O
NOT	O	O
DEVIATED	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
PERSISTENT	O	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
PERICARDIAL	3_Yellow_Days	3_Yellow_Days
EFFUSION	3_Yellow_Days	3_Yellow_Days
.	O	O
THERE	O	O
IS	O	O
EDEMA	3_Yellow_Days	3_Yellow_Days
THROUGHOUT	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
MEDIASTINUM	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
PREVIOUSLY	O	O
SEEN	O	O
ADENOPATHY	3_Yellow_Days	O
IN	3_Yellow_Days	O
BOTH	3_Yellow_Days	O
PULMONARY	3_Yellow_Days	3_Yellow_Days
HILA	3_Yellow_Days	3_Yellow_Days
IS	3_Yellow_Days	3_Yellow_Days
STABLE	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
LARGEST	3_Yellow_Days	O
NODES	3_Yellow_Days	O
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
RIGHT	3_Yellow_Days	O
HILUM	3_Yellow_Days	O
MEASURE	3_Yellow_Days	O
UP	3_Yellow_Days	O
TO	3_Yellow_Days	O
29	3_Yellow_Days	O
X	3_Yellow_Days	O
24	3_Yellow_Days	O
MM	3_Yellow_Days	O
AND	O	O
ON	O	1_Red_Minutes
THE	O	1_Red_Minutes
LEFT	3_Yellow_Days	1_Red_Minutes
SIDE	3_Yellow_Days	O
UP	3_Yellow_Days	O
TO	3_Yellow_Days	O
19	3_Yellow_Days	O
X	3_Yellow_Days	O
16	3_Yellow_Days	O
MM	3_Yellow_Days	O
.	O	O
THERE	O	O
IS	O	O
SIGNIFICANT	1_Red_Minutes	3_Yellow_Days
AMOUNT	1_Red_Minutes	3_Yellow_Days
OF	1_Red_Minutes	3_Yellow_Days
SECRETIONS	1_Red_Minutes	3_Yellow_Days
WITHIN	1_Red_Minutes	3_Yellow_Days
THE	1_Red_Minutes	3_Yellow_Days
LEFT	1_Red_Minutes	3_Yellow_Days
MAIN	1_Red_Minutes	3_Yellow_Days
STEM	1_Red_Minutes	3_Yellow_Days
BRONCHUS	1_Red_Minutes	3_Yellow_Days
.	O	O
AN	O	O
ENDOTRACHEAL	1_Red_Minutes	O
TUBE	1_Red_Minutes	O
IS	1_Red_Minutes	O
SEEN	1_Red_Minutes	O
IN	1_Red_Minutes	O
THE	1_Red_Minutes	O
PROXIMAL	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
MAIN	1_Red_Minutes	O
STEM	1_Red_Minutes	O
BRONCHUS	1_Red_Minutes	O
.	O	O
THE	O	O
NG	O	O
TUBE	O	O
IS	O	O
IN	O	O
PLACE	O	O
.	O	O
THE	O	O
ESOPHAGUS	O	O
IS	O	O
UNREMARKABLE	O	O
.	O	O
SEVERE	3_Yellow_Days	O
______	3_Yellow_Days	O
PANLOBULAR	3_Yellow_Days	O
EMPHYSEMA	3_Yellow_Days	O
IS	O	O
NOTED	O	O
THROUGHOUT	O	3_Yellow_Days
BOTH	3_Yellow_Days	3_Yellow_Days
LUNGS	3_Yellow_Days	3_Yellow_Days
.	O	O
THERE	O	O
ARE	O	O
ALSO	O	O
PERSISTENT	3_Yellow_Days	3_Yellow_Days
DIFFUSE	3_Yellow_Days	3_Yellow_Days
AREAS	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	O
MOSAIC	3_Yellow_Days	O
PERFUSION	3_Yellow_Days	O
,	3_Yellow_Days	O
STABLE	3_Yellow_Days	O
IN	O	O
APPEARANCE	O	O
.	O	O
DUE	O	O
TO	O	O
THEIR	O	3_Yellow_Days
STABILITY	O	3_Yellow_Days
OVERTIME	O	3_Yellow_Days
THESE	O	3_Yellow_Days
ARE	O	3_Yellow_Days
THOUGHT	O	3_Yellow_Days
TO	O	3_Yellow_Days
REPRESENT	O	3_Yellow_Days
CHANGES	O	3_Yellow_Days
SECONDARY	O	3_Yellow_Days
TO	O	O
SMALL	O	O
AIRWAYS	O	O
DISEASE	O	O
.	O	O
MILD	3_Yellow_Days	3_Yellow_Days
BRONCHIECTASIS	3_Yellow_Days	3_Yellow_Days
IS	O	O
ALSO	O	O
SEEN	O	O
THROUGHOUT	3_Yellow_Days	O
BOTH	3_Yellow_Days	O
LUNGS	3_Yellow_Days	O
.	O	O
SOME	3_Yellow_Days	O
OF	O	O
THE	O	O
PERIPHERAL	O	O
BRONCHI	O	O
APPEAR	O	O
THICK	O	O
,	O	O
LIKELY	O	O
RELATED	O	O
TO	O	O
PERIBRONCHIAL	3_Yellow_Days	3_Yellow_Days
EDEMA	3_Yellow_Days	3_Yellow_Days
.	O	O
THERE	O	O
IS	O	O
A	O	O
PERSISTENT	O	3_Yellow_Days
NODULAR	O	3_Yellow_Days
SCAR	O	3_Yellow_Days
IN	O	3_Yellow_Days
THE	O	3_Yellow_Days
MEDIAL	O	3_Yellow_Days
ASPECT	O	3_Yellow_Days
OF	O	3_Yellow_Days
THE	O	3_Yellow_Days
LEFT	O	3_Yellow_Days
LUNG	O	3_Yellow_Days
WITH	O	3_Yellow_Days
A	O	3_Yellow_Days
CENTRAL	O	3_Yellow_Days
CALCIFICATION	O	3_Yellow_Days
.	O	O
THERE	O	O
IS	O	O
A	O	O
NEW	1_Red_Minutes	1_Red_Minutes
NODULAR	1_Red_Minutes	1_Red_Minutes
DENSITY	1_Red_Minutes	1_Red_Minutes
IN	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
POSTERIOR	1_Red_Minutes	1_Red_Minutes
ASPECT	1_Red_Minutes	1_Red_Minutes
OF	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
UPPER	1_Red_Minutes	1_Red_Minutes
LOBE	1_Red_Minutes	1_Red_Minutes
-LRB-	O	O
IMAGE	O	O
#	O	O
72	O	O
-RRB-	O	O
,	O	O
MEASURING	O	O
ABOUT	O	O
8	1_Red_Minutes	O
X	1_Red_Minutes	O
6	1_Red_Minutes	O
MM	1_Red_Minutes	O
IN	1_Red_Minutes	O
DIAMETER	1_Red_Minutes	O
.	O	O
SEVERAL	3_Yellow_Days	O
OTHER	O	O
NODULAR	3_Yellow_Days	O
SCARS	3_Yellow_Days	O
ARE	O	O
SEEN	O	O
IN	O	O
THE	O	O
RIGHT	3_Yellow_Days	O
LOWER	3_Yellow_Days	O
LOBE	3_Yellow_Days	O
-LRB-	O	O
IMAGE	O	O
#	O	O
181	O	O
-RRB-	O	O
,	O	O
AND	3_Yellow_Days	O
IN	O	O
THE	O	O
SUPERIOR	3_Yellow_Days	1_Red_Minutes
SEGMENT	3_Yellow_Days	1_Red_Minutes
FOR	3_Yellow_Days	1_Red_Minutes
THE	3_Yellow_Days	1_Red_Minutes
LEFT	3_Yellow_Days	1_Red_Minutes
LOWER	3_Yellow_Days	1_Red_Minutes
LOBE	3_Yellow_Days	1_Red_Minutes
-LRB-	O	O
IMAGE	O	O
#	O	O
77	O	O
-RRB-	O	O
.	O	O
SEVERAL	3_Yellow_Days	O
OTHER	3_Yellow_Days	3_Yellow_Days
TINY	3_Yellow_Days	3_Yellow_Days
SUBCENTIMETER	3_Yellow_Days	3_Yellow_Days
NODULES	3_Yellow_Days	3_Yellow_Days
APPEAR	O	3_Yellow_Days
TO	O	3_Yellow_Days
BE	O	3_Yellow_Days
STABLE	3_Yellow_Days	3_Yellow_Days
IN	3_Yellow_Days	O
SIZE	3_Yellow_Days	O
AND	3_Yellow_Days	O
NUMBER	3_Yellow_Days	O
.	O	O
THERE	O	O
ARE	O	O
NO	O	O
PLEURAL	O	O
EFFUSIONS	O	O
.	O	O
THERE	O	O
IS	O	O
DIFFUSE	1_Red_Minutes	3_Yellow_Days
ASCITES	1_Red_Minutes	3_Yellow_Days
AS	1_Red_Minutes	3_Yellow_Days
A	1_Red_Minutes	3_Yellow_Days
NEW	1_Red_Minutes	3_Yellow_Days
FINDING	1_Red_Minutes	3_Yellow_Days
.	O	O
THE	O	O
LIVER	3_Yellow_Days	O
IS	3_Yellow_Days	O
HETEROGENEOUS	3_Yellow_Days	O
,	O	O
ALTHOUGH	O	O
THE	O	O
SIGNIFICANCE	O	O
OF	O	O
THIS	O	O
FINDING	O	O
IS	O	O
UNCERTAIN	O	O
IN	O	O
THIS	O	O
SINGLE	O	O
PHASE	O	O
STUDY	O	O
.	O	O
THE	O	O
UTERUS	O	O
APPEARS	O	O
FIBROMATOUS	O	O
,	O	O
ALTHOUGH	O	O
UNCHANGED	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
SIGNIFICANT	1_Red_Minutes	3_Yellow_Days
AMOUNT	1_Red_Minutes	3_Yellow_Days
OF	1_Red_Minutes	3_Yellow_Days
FLUID	1_Red_Minutes	3_Yellow_Days
IN	1_Red_Minutes	3_Yellow_Days
THE	1_Red_Minutes	3_Yellow_Days
PELVIS	1_Red_Minutes	3_Yellow_Days
.	O	O
A	O	O
BLADDER	O	O
CATHETER	O	O
IS	O	O
SEEN	O	O
IN	O	O
PLACE	O	O
.	O	O
THERE	O	O
ARE	O	O
NO	O	O
SIGNS	O	O
OF	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	O
DVT	O	O
.	O	O
THERE	O	O
IS	O	O
DIFFUSE	3_Yellow_Days	3_Yellow_Days
EDEMA	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
LOWER	3_Yellow_Days	O
EXTREMITIES	3_Yellow_Days	O
.	O	O
THERE	O	O
ARE	O	O
NO	O	O
FOCAL	O	O
BONY	O	O
LESIONS	O	O
.	O	O
1	O	O
.	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	3_Yellow_Days
PE	O	3_Yellow_Days
OR	O	3_Yellow_Days
DVT	O	3_Yellow_Days
.	O	O
2	O	O
.	O	O
UNCHANGED	O	3_Yellow_Days
DIFFUSE	1_Red_Minutes	3_Yellow_Days
CARDIOMEGALY	1_Red_Minutes	3_Yellow_Days
.	O	O
SIGNS	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
HYPERTENSION	3_Yellow_Days	3_Yellow_Days
.	O	O
3	O	O
.	O	O
STABLE	3_Yellow_Days	3_Yellow_Days
BILATERAL	3_Yellow_Days	3_Yellow_Days
HILAR	3_Yellow_Days	3_Yellow_Days
ADENOPATHY	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
POSSIBILITY	3_Yellow_Days	O
OF	3_Yellow_Days	O
SARCOID	3_Yellow_Days	O
IS	O	O
RAISED	O	O
.	O	O
UNCHANGED	3_Yellow_Days	O
COPD	3_Yellow_Days	O
FINDINGS	3_Yellow_Days	O
.	O	O
4	O	O
.	O	O
NO	O	O
CHANGE	O	O
IN	O	O
THE	O	O
MOSAIC	O	3_Yellow_Days
PERFUSION	O	3_Yellow_Days
PATTERN	O	3_Yellow_Days
PROBABLY	O	3_Yellow_Days
DUE	O	3_Yellow_Days
TO	O	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
AIRWAYS	3_Yellow_Days	3_Yellow_Days
DISEASE	3_Yellow_Days	3_Yellow_Days
.	O	O
5	O	O
.	O	O
BILATERAL	3_Yellow_Days	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
NODULES	3_Yellow_Days	3_Yellow_Days
AND	3_Yellow_Days	3_Yellow_Days
NODULAR	3_Yellow_Days	3_Yellow_Days
SCARS	3_Yellow_Days	3_Yellow_Days
.	O	O
AT	O	O
LEAST	O	O
THE	O	O
NODULAR	1_Red_Minutes	3_Yellow_Days
SCAR	1_Red_Minutes	3_Yellow_Days
DESCRIBING	1_Red_Minutes	3_Yellow_Days
THE	1_Red_Minutes	3_Yellow_Days
RIGHT	1_Red_Minutes	3_Yellow_Days
UPPER	1_Red_Minutes	3_Yellow_Days
LOBE	1_Red_Minutes	3_Yellow_Days
IS	1_Red_Minutes	3_Yellow_Days
NEW	1_Red_Minutes	3_Yellow_Days
.	O	O
A	O	O
FOLLOW-UP	1_Red_Minutes	O
IN	1_Red_Minutes	O
THREE	1_Red_Minutes	O
TO	1_Red_Minutes	O
SIX	1_Red_Minutes	3_Yellow_Days
MONTHS	1_Red_Minutes	3_Yellow_Days
IS	1_Red_Minutes	3_Yellow_Days
RECOMMENDED	1_Red_Minutes	3_Yellow_Days
.	O	O
6	O	O
.	O	O
ET	1_Red_Minutes	O
TUBE	1_Red_Minutes	O
IN	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
MAIN	1_Red_Minutes	O
STEM	1_Red_Minutes	O
BRONCHUS	1_Red_Minutes	O
.	O	O
7	O	O
.	O	O
NG	O	O
TUBE	O	O
IN	O	O
PLACE	O	O
.	O	O
8	O	O
.	O	O
NEW	1_Red_Minutes	3_Yellow_Days
ASCITES	1_Red_Minutes	3_Yellow_Days
.	O	O
9	O	O
.	O	O
GENERALIZED	3_Yellow_Days	O
SUBCUTANEOUS	3_Yellow_Days	O
EDEMA	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
FINDINGS	3_Yellow_Days	O
WERE	3_Yellow_Days	O
DISCUSSED	3_Yellow_Days	O
WITH	3_Yellow_Days	O
THE	3_Yellow_Days	O
PHYSICIAN	3_Yellow_Days	O
IN	3_Yellow_Days	O
CHARGE	3_Yellow_Days	O
AT	3_Yellow_Days	O
6:00	3_Yellow_Days	O
PM	3_Yellow_Days	O
ON	3_Yellow_Days	O
05/03	3_Yellow_Days	O
.	O	O
+	O	O
EXAMINATION	O	O
REVIEWED	O	O
&	O	O
REPORTED	O	O
FINDINGS	O	O
CONFIRMED	O	O
BY	O	O
:	O	O
-LSB-	O	O
doctor	O	O
-RSB-	O	O
.	O	O
71250	O	O
CT	O	O
CHEST	O	O
wo	O	O
CT	O	O
05/09/2007	O	O
ES	O	O
>	O	O
<	O	O
REPOUnenhanced	O	O
chest	O	O
CT	O	O
compared	O	O
to	O	O
prior	O	O
examination	O	O
dated	O	O
10-23-06	O	O
,	O	O
shows	O	O
no	O	O
interval	O	O
change	O	O
.	O	O
PO	O	O
left	O	O
pneumonectomy	O	O
.	O	O
Small	3_Yellow_Days	3_Yellow_Days
irregular	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
lung	3_Yellow_Days	O
are	3_Yellow_Days	O
unchanged	3_Yellow_Days	O
from	3_Yellow_Days	O
previous	3_Yellow_Days	O
study	3_Yellow_Days	O
of	3_Yellow_Days	O
9-27-04	3_Yellow_Days	O
,	3_Yellow_Days	O
and	3_Yellow_Days	O
,	3_Yellow_Days	O
therefore	3_Yellow_Days	O
,	3_Yellow_Days	O
should	3_Yellow_Days	3_Yellow_Days
be	3_Yellow_Days	3_Yellow_Days
benign	3_Yellow_Days	3_Yellow_Days
.	O	O
No	O	O
new	O	O
pulmonary	O	O
nodules	O	O
.	O	O
No	O	O
lymphadenopathy	O	O
.	O	O
Mild	3_Yellow_Days	O
changes	3_Yellow_Days	O
of	3_Yellow_Days	O
emphysema	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
lung	3_Yellow_Days	O
.	O	O
Slight	O	3_Yellow_Days
fibrosis	O	3_Yellow_Days
right	O	3_Yellow_Days
base	O	3_Yellow_Days
.	O	O
Vascular	O	O
including	O	O
coronary	3_Yellow_Days	3_Yellow_Days
artery	3_Yellow_Days	3_Yellow_Days
calcifications	3_Yellow_Days	3_Yellow_Days
.	O	O
348955109	O	O
111052	O	O
IMGCTT	O	O
CT	O	O
THORAX	O	O
NONCONTRAST	O	O
CHEST	O	O
CT	O	O
:	O	O
04/06/2009	O	O
TECHNIQUE	O	O
:	O	O
Following	O	O
acquisition	O	O
of	O	O
two	O	O
scout	O	O
images	O	O
,	O	O
a	O	O
noncontrast	O	O
helical	O	O
CT	O	O
of	O	O
the	O	O
chest	O	O
was	O	O
performed	O	O
with	O	O
reconstruction	O	O
into	O	O
0.625	O	O
mm	O	O
slices	O	O
.	O	O
Axial	O	O
reformations	O	O
were	O	O
obtained	O	O
in	O	O
1.25	O	O
and	O	O
5	O	O
mm	O	O
slices	O	O
.	O	O
Images	O	O
were	O	O
also	O	O
reformatted	O	O
into	O	O
coronal	O	O
and	O	O
sagittal	O	O
planes	O	O
.	O	O
Axial	O	O
MIP	O	O
images	O	O
were	O	O
provided	O	O
.	O	O
CLINICAL	O	O
HISTORY	O	O
:	O	O
A	O	O
76-year-old	O	O
female	O	O
,	O	O
no	O	O
history	O	O
provided	O	O
.	O	O
COMPARISON	O	O
:	O	O
None	O	O
.	O	O
FINDINGS	O	O
:	O	O
The	O	O
main	3_Yellow_Days	O
pulmonary	3_Yellow_Days	O
artery	3_Yellow_Days	O
measures	3_Yellow_Days	O
3	3_Yellow_Days	O
cm	3_Yellow_Days	O
in	O	O
diameter	3_Yellow_Days	O
which	3_Yellow_Days	O
is	3_Yellow_Days	O
nonspecific	3_Yellow_Days	O
but	3_Yellow_Days	O
may	3_Yellow_Days	O
be	3_Yellow_Days	O
seen	3_Yellow_Days	O
in	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
setting	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
arterial	3_Yellow_Days	3_Yellow_Days
hypertension	3_Yellow_Days	3_Yellow_Days
.	O	O
Mild	3_Yellow_Days	3_Yellow_Days
coronary	3_Yellow_Days	3_Yellow_Days
calcifications	3_Yellow_Days	3_Yellow_Days
and	O	O
mild	3_Yellow_Days	3_Yellow_Days
atherosclerotic	3_Yellow_Days	3_Yellow_Days
calcifications	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
aorta	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	3_Yellow_Days
its	3_Yellow_Days	O
branches	3_Yellow_Days	O
are	3_Yellow_Days	O
demonstrated	3_Yellow_Days	O
.	O	O
The	O	O
pericardium	O	O
is	O	O
within	O	O
normal	O	O
limits	O	O
.	O	O
Subcentimeter	O	O
mediastinal	O	O
nodes	O	O
are	O	O
present	O	O
.	O	O
There	O	O
is	O	O
no	O	O
obvious	O	O
hilar	O	O
adenopathy	O	O
,	O	O
although	O	O
evaluation	O	O
is	O	O
limited	O	O
without	O	O
intravenous	O	O
contrast	O	O
.	O	O
There	O	O
may	O	O
be	O	O
a	O	O
small	O	3_Yellow_Days
calcified	O	3_Yellow_Days
left	O	3_Yellow_Days
hilar	O	3_Yellow_Days
node	O	3_Yellow_Days
.	O	O
A	O	O
focal	O	3_Yellow_Days
filling	O	3_Yellow_Days
defect	O	3_Yellow_Days
in	O	3_Yellow_Days
the	O	3_Yellow_Days
trachea	O	3_Yellow_Days
is	O	3_Yellow_Days
nonspecific	O	3_Yellow_Days
but	O	O
could	O	O
represent	O	O
minor	O	O
airway	O	O
secretions	O	O
.	O	O
No	O	O
pleural	O	O
effusion	O	O
or	O	O
pneumothorax	O	O
is	O	O
identified	O	O
.	O	O
There	O	O
are	O	O
scattered	3_Yellow_Days	3_Yellow_Days
areas	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
mild	3_Yellow_Days	3_Yellow_Days
bronchiectasis	3_Yellow_Days	3_Yellow_Days
.	O	O
Scattered	O	3_Yellow_Days
areas	O	3_Yellow_Days
of	O	3_Yellow_Days
linear	O	3_Yellow_Days
atelectasis/scarring	O	3_Yellow_Days
are	O	O
noted	O	O
at	O	O
the	O	O
lung	O	O
bases	O	O
.	O	O
Some	3_Yellow_Days	O
mucus	3_Yellow_Days	O
plugging	3_Yellow_Days	O
is	3_Yellow_Days	O
noted	3_Yellow_Days	O
.	O	O
Multiple	O	O
hepatic	O	O
cysts	O	O
are	O	O
demonstrated	O	O
,	O	O
the	O	O
largest	O	3_Yellow_Days
in	O	1_Red_Minutes
the	O	1_Red_Minutes
right	O	1_Red_Minutes
hepatic	O	1_Red_Minutes
lobe	O	1_Red_Minutes
measuring	O	O
2.8	O	O
x	O	O
3.4	O	O
cm	O	O
.	O	O
Additional	O	O
subcentimeter	O	O
hypodensities	O	O
in	O	O
the	O	O
liver	O	O
are	O	O
too	O	3_Yellow_Days
small	O	3_Yellow_Days
to	O	3_Yellow_Days
characterize	O	3_Yellow_Days
.	O	O
The	O	O
gallbladder	O	O
has	O	O
been	O	O
surgically	O	O
removed	O	O
.	O	O
There	O	O
is	O	O
prominence	3_Yellow_Days	O
of	3_Yellow_Days	O
the	3_Yellow_Days	O
intra	3_Yellow_Days	O
and	3_Yellow_Days	O
extrahepatic	3_Yellow_Days	3_Yellow_Days
biliary	3_Yellow_Days	3_Yellow_Days
system	3_Yellow_Days	3_Yellow_Days
.	O	O
The	O	O
common	3_Yellow_Days	O
bile	3_Yellow_Days	O
duct	3_Yellow_Days	O
is	3_Yellow_Days	O
partially	3_Yellow_Days	O
imaged	3_Yellow_Days	O
and	3_Yellow_Days	O
measures	3_Yellow_Days	O
up	3_Yellow_Days	O
to	3_Yellow_Days	O
1.2	3_Yellow_Days	O
cm	3_Yellow_Days	O
.	O	O
The	O	O
osseous	O	O
structures	O	O
demonstrate	O	O
mild	O	O
degenerative	O	O
changes	O	O
.	O	O
IMPRESSION	O	O
:	O	O
1	O	O
.	O	O
SCATTERED	3_Yellow_Days	O
AREAS	3_Yellow_Days	O
OF	3_Yellow_Days	O
MILD	3_Yellow_Days	3_Yellow_Days
BRONCHIECTASIS	3_Yellow_Days	3_Yellow_Days
.	O	O
2	O	O
.	O	O
FOCAL	3_Yellow_Days	3_Yellow_Days
FILLING	3_Yellow_Days	3_Yellow_Days
DEFECT	3_Yellow_Days	3_Yellow_Days
IN	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
TRACHEA	3_Yellow_Days	3_Yellow_Days
WHICH	3_Yellow_Days	O
IS	3_Yellow_Days	O
NONSPECIFIC	3_Yellow_Days	O
BUT	3_Yellow_Days	O
MAY	3_Yellow_Days	O
REPRESENT	3_Yellow_Days	O
SECRETIONS	3_Yellow_Days	O
.	O	O
CLINICAL	3_Yellow_Days	O
CORRELATION	3_Yellow_Days	O
AND	3_Yellow_Days	O
COMPARISON	3_Yellow_Days	O
WITH	3_Yellow_Days	O
ANY	3_Yellow_Days	O
AVAILABLE	3_Yellow_Days	O
PRIOR	3_Yellow_Days	O
EXAMS	3_Yellow_Days	O
IS	3_Yellow_Days	O
SUGGESTED	3_Yellow_Days	O
.	O	O
3	O	O
.	O	O
PROMINENCE	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
INTRA	3_Yellow_Days	O
AND	3_Yellow_Days	O
EXTRAHEPATIC	3_Yellow_Days	O
BILIARY	3_Yellow_Days	O
SYSTEM	3_Yellow_Days	O
WITH	O	O
THE	O	O
PARTIALLY	O	O
IMAGED	O	O
COMMON	3_Yellow_Days	3_Yellow_Days
BILE	3_Yellow_Days	3_Yellow_Days
DUCT	3_Yellow_Days	3_Yellow_Days
MEASURING	3_Yellow_Days	3_Yellow_Days
UP	3_Yellow_Days	3_Yellow_Days
TO	3_Yellow_Days	O
1.2	3_Yellow_Days	O
CM	3_Yellow_Days	O
IN	3_Yellow_Days	O
DIAMETER	3_Yellow_Days	O
.	O	O
AGAIN	O	O
,	O	O
CLINICAL	3_Yellow_Days	3_Yellow_Days
CORRELATION	3_Yellow_Days	3_Yellow_Days
AND	3_Yellow_Days	O
COMPARISON	3_Yellow_Days	O
WITH	3_Yellow_Days	O
AVAILABLE	3_Yellow_Days	O
PRIOR	3_Yellow_Days	O
EXAMS	3_Yellow_Days	O
ARE	3_Yellow_Days	O
SUGGESTED	3_Yellow_Days	O
.	O	O
OTHERWISE	3_Yellow_Days	O
,	3_Yellow_Days	O
AN	3_Yellow_Days	O
ULTRASOUND	3_Yellow_Days	O
MAY	3_Yellow_Days	O
BE	3_Yellow_Days	O
OBTAINED	3_Yellow_Days	O
FOR	3_Yellow_Days	O
FURTHER	3_Yellow_Days	O
EVALUATION	3_Yellow_Days	O
IF	3_Yellow_Days	O
INDICATED	3_Yellow_Days	O
.	O	O
SUMMARY	O	O
:4	O	O
-	O	O
POSSIBLE	O	O
SIGNIFICANT	O	O
FINDINGS	O	O
,	O	O
MAY	O	O
NEED	O	O
ACTION	O	O
.	O	O
I	O	O
have	O	O
personally	O	O
reviewed	O	O
the	O	O
images	O	O
for	O	O
this	O	O
examination	O	O
and	O	O
agreed	O	O
with	O	O
the	O	O
report	O	O
transcribed	O	O
above	O	O
.	O	O

